Baicalin

Baicalin is a naturally occurring flavone glycoside, more precisely a flavonoid glucuronide, formed when the flavone baicalein carries an attached glucuronic acid group at its 7-position ^[1]. It is one of the most abundant flavonoids in the dried root of Scutellaria baicalensis, the Baikal or Chinese skullcap, and it also occurs in related species such as Scutellaria lateriflora and Scutellaria galericulata and in Oroxylum indicum ^[1]. The root, known as Huang Qin, has been used in traditional Chinese medicine for centuries and appears in classic multiherb formulas such as Sho-Saiko-To and Shuanghuanglian ^[1].

Within the plant, baicalin is made from baicalein by the enzyme baicalein 7-O-glucuronosyltransferase, which transfers a glucuronic acid unit onto the flavone ^[1]. The relationship between the two compounds continues inside the body: after it is swallowed, gut bacteria hydrolyze baicalin to its aglycone baicalein, which is more readily absorbed, and the liver can then reattach glucuronic acid to regenerate baicalin through phase 2 metabolism ^[4]. A recurring practical limitation is that baicalin is poorly soluble and poorly absorbed, giving it low oral bioavailability that has driven interest in improved delivery formulations ^[1].

Baicalin has been examined across a wide spectrum of biological activities in laboratory and animal studies, including anti-inflammatory, antioxidant, antiviral, antibacterial, antitumor, anticonvulsant, hepatoprotective, and neuroprotective effects ^[1]. A well-characterized action is on the nervous system: baicalin behaves as a positive modulator at the benzodiazepine site of the GABA-A receptor and produced anxiety-reducing effects in mice without the sedation or muscle relaxation typical of classic benzodiazepines, showing a preference for receptors that contain the alpha-2 and alpha-3 subunits ^[2][3]. Other research has focused on the liver and gut, where baicalin showed protective effects in models of liver injury, fibrosis, fatty liver disease, and colitis by modulating inflammatory and fibrotic signaling pathways ^[4], and on metabolic disease, where baicalin and baicalein have been studied for effects on insulin resistance, obesity, and blood lipids ^[5].

Despite this breadth of preclinical evidence, baicalin is not an approved stand-alone medicine in Western countries; it is met mainly as a constituent of skullcap-based herbal products and traditional formulas, and as a research compound ^[1]. Rigorous large-scale human trials establishing clinical benefit are lacking, and its low bioavailability remains a hurdle to therapeutic use ^[1][4].

Generally well tolerated, with mild GI upset being the most common issue. Like baicalein it may affect drug-metabolizing enzymes and clotting, so caution with anticoagulants and other medications is sensible. Long-term human safety data is limited, and pregnancy safety isn't established.